Market Overview

Transradial Access Devices Market by Product, by Application, End User & Geography - Global Market to 2023 -


The "Transradial
Access Devices Market by Product, by Application, by End User, by
Geography - Global Market Size, Share, Development, Growth, and Demand
Forecast, 2013 - 2023"
report has been added to's

Global transradial access devices market size is forecasted to reach
$24.1 billion by 2023.

The cost-benefit associated with transradial artery access, increasing
preference of radial artery access for interventional procedures,
increasing prevalence of chronic diseases, increasing number of
chemotherapy procedures, growing use of radial access devices in
geriatric as well as high risk patients, and rising healthcare
expenditure are the key factors driving the growth of the transradial
access market.

On the basis of product, the transradial access devices market has been
categorized into catheters, guidewires, sheaths and sheath introducers,
and accessories. Of these, the fastest growth during the forecast period
is expected from catheters, with 9.0% CAGR. This is mainly attributed to
the adoption of miniaturized diagnostic catheters such as 4F and 5F

Among all applications of transradial access devices, drug
administration is expected to be the fastest growing category, with CAGR
of 8.9% during the forecast period. This can be attributed to the
increased use of vascular access devices over others. On the basis of
end user, hospitals have been the dominant category, with a share of
76.4% in 2017. This can be ascribed to the large patient base being
treated with transradial access approach and the increasing number of
procedures being conducted in cath labs in hospitals.

Market Dynamics


  • Collaborations With Medical Device Reprocessing Players
  • Increasing Focus On Development Of Robotic-Assisted Catheter Systems
  • Growing Focus Of Market Players On Emerging Economies


  • Cost-Benefit Associated With Transradial Artery Access
  • Increasing Preference Of Radial Artery Access For Interventional
  • Increasing Prevalence Of Chronic Diseases
  • Increasing Number Of Chemotherapy Procedures
  • Growing Use Of Radial Access Devices In Geriatric As Well As High Risk
  • Rising Healthcare Expenditure


  • Dearth Of Highly Skilled Professionals
  • Product Recalls And Failures


  • Technological Advancements In Transradial Access Devices
  • Increasing Acquisition And Collaboration Between Players

Company Profiles

  • Terumo Corporation
  • Becton, Dickinson And Company
  • Medtronic Plc
  • Smith Group Plc
  • Edwards Lifesciences Corporation
  • Angiodynamics Inc.
  • Merit Medical Systems Inc.
  • Teleflex Incorporated
  • Nipro Corporation
  • Boston Scientific Corporation

For more information about this report visit

View Comments and Join the Discussion!